Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
India’s pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various ...
Latest Post
India-US trade deal: How Delhi’s behind-the-scenes push cracked Trump tariff wall
India and the US have reached a surprising trade deal, reducing tariffs on Indian goods to 18% after a year of strained relations. National Security ...
US markets today: Wall street opens mixed as tech stocks weigh; gold climbs back above $5,000 per ounce
No valid response from Gemini.
Rail modernisation: Railways plans 260 Vande Bharat sleeper rakes; phased rollout with advanced safety, comfort features
No valid response from Gemini.
Is another repo rate cut on the table as RBI MPC meets? What to expect from Friday’s policy outcome
No valid response from Gemini.